Eleven Biotherapeutics reported $800.59M in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Amgen AMGN:US $ 140.05B 3.22B
Bayer BAYN:GR 50.48B 2.53B
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Corcept Therapeutics CORT:US $ 2.57B 205.11M
Eleven Biotherapeutics EBIO:US $ 800.59M 360.18M
Eli Lilly And LLY:US $ 220.12B 40.96B
Intrexon XON:US $ 1.35B 76.37M
Merk MRK:US $ 196918.18M 1780.24M
Pfizer PFE:US $ 219205.69M 17108.81M
Rigel Pharmaceuticals RIGL:US $ 738.51M 156.7M
X T L Biopharmaceuticals XTLB:US 15.7M 6.23M
Ziopharm Oncology ZIOP:US $ 568.99M 205.75M